Home
Business
Companies
Technology
Value Stocks

Regeneron Pharmaceuticals

How Do Analysts Perceive Regeneron Pharmaceuticals, Inc (REGN)?

October 2, 2025

Heidi Phillips

Regeneron Pharmaceuticals, Inc (REGN) saw an uptrend of 6.70% in the recent trading with $599.94 being its most recent. The ...

Most recent

Companies

Emergent Biosolutions Inc (NYSE:EBS) trading 128.61% higher than its 52 week low: What does Wall Street Say?

Business

Jamf Holding Corp (NASDAQ:JAMF) loss -3.36% – Is It right time to buy?

Technology

How Do Analysts Perceive Eastman Kodak Co (KODK)?

Value Stocks

What Are Analyst Opinions Regarding Eastern Bankshares Inc (EBC)?

Companies

How Do Analysts Feel About Ormat Technologies Inc (ORA)?

Business

What Do Analysts Have To Say About Gentex Corp (GNTX)

Who We Are?

At BaxterReport.com, we provide unique stock market insights, focusing on the fundamentals of under-the-radar stocks and covering pre, post, and intraday trades for both short- and long-term investors.

Useful Links

About Us
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled